The mitogen-activated protein (MAP) kinase c-Jun N-terminal kinase 3 (JNK3) is one of the key signaling enzymes in the cellular stress response and has been targeted for the treatment of neurodegenerative diseases, including Alzheimer’s and Parkinson’s disease [70]. This evidence concerns the gene MAPK10 and neurodegenerative disease.